Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment
Vassilios Aslanis, Michael A. Gray, Robert J. Slack, Fredrik R. Zetterberg, Dimitar Tonev, De Phung, Becky Smith, Brian Jacoby, Hans Schambye, Zahari Krastev, Anna‐Lena Ungell, Bertil Lindmark
Topics & Concepts
MedicinePharmacokineticsPharmacologyPharmacotherapyIntensive care medicineInternal medicineGalectins and Cancer BiologyStudies on Chitinases and ChitosanasesGlycosylation and Glycoproteins Research